Cadila Pharmaceuticals
Highly Engaged Employees
Manufacturing · India · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Sarkhej-dholka Bhat Rd, Sarkhej, Gujarat...Phone Number
+91 2718351000Website
www.cadilapharma.comRevenue
$2.4 BillionIndustry
About Cadila Pharmaceuticals
Cadila Pharmaceuticals Org Chart
Is Cadila Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cadila Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Cadila Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cadila Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Cadila Pharmaceuticals
Product Launch: Get notified when Cadila Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Cadila Pharmaceuticals has new funding data
Check out if Cadila Pharmaceuticals is spiking on competitors!
Check if Cadila Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Cadila Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Cadila Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cadila Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cadila Pharmaceuticals.
Cadila Pharmaceuticals Tech Stack
A closer look at the technologies used by Cadila Pharmaceuticals
Most Recent Scoops
Cadila Pharmaceuticals News & Media
Cadila Healthcare's US arm receives FDA nod to market Pimavanserin capsule
Cadila Healthcare on Friday said its US arm Zydus Pharmaceuticals (USA) Inc has received tentative approval from the US health regulator to market generic Pimavanserin capsules, indicated for treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The approval by the US Food & Drug Administration for the generic Pimavanserin capsules is for the strength of 34 mg, Cadila Healthcare said in a regulatory filing. "The drug will be manufactured at the group's formulatUSD 444.54 mn growth for Dravet Syndrome Treatment Market by 2025 |Evolving Opportunities with Cadila Healthcare Ltd. & Epygenix Therapeutics Inc.|17000+ Technavio Reports
NEW YORK, Nov. 25, 2021 /PRNewswire/ -- The "Dravet Syndrome Treatment Market - Competitive Analysis, Trends, Drivers, Challenges, and Five Force Analysis" report has been added to Technavio's offering. The dravet syndrome treatment market size is expected to increase by USD 444.54...Cadila Healthcare Q2 PAT up by 6% YoY to Rs 597 cr, revenue up 3%
The company's EBIDTA margin for the quarter was 22.7 per cent, up by 50 basis pointsZydus Cadila gets tentative nod from USFDA to market generic acne drug
Drug firm Zydus Cadila on Friday said it has received tentative nod from the US health regulator to market generic Adapalene and Benzoyl Peroxide gel used for treatment of acne in the American market. The company has received tentative approval from the United States Food and Drug Administration (USFDA) to market Adapalene and Benzoyl Peroxide Gel 0.3 per cent/2.5 per cent, Zydus Cadila said in a statement. The drug will be manufactured at the group's
Top Manufacturing Companies
Frequently Asked Questions Regarding Cadila Pharmaceuticals
Founded in 1951, Cadila Pharmaceuticals is a privately held pharmaceutical company in India. The company's integrated operations cover the entire gamut from manufacturing products ranging from API's-Intermediates, finished formulations, OTC-Food Supplements, Biotechnology Products, and pharmaceutical Machinery.... Read More